INFECTION

More news
IBTimes Logo

Scientists Develop New Tuberculosis Vaccine

Scientists have made a significant advancement in the development of a new vaccine against tuberculosis, which is responsible for approximately 1.7 million deaths worldwide, annually.

HIV-positive Performer Shuts Down LA Porn Industry, Identity Unclear

An adult actor who contracted HIV through unprotected sex shut down Los Angeles' adult film industry Monday night. An involuntary sexual health database was established less than a month ago in order to curtail the spread of sexually transmitted disease within the notoriously promiscuous community.
IBTimes Logo

HIV-Positive Performer Shuts Down L.A.’s Billion-dollar Porn Industry

An adult film performer has tested positive for HIV, prompting a temporary shutdown of the billion-dollar porn industry in Los Angeles on Monday night. Porn producers shut down the shoots in Southern California as the diagnosis is confirmed through retesting, an industry group told the media
IBTimes Logo

FDA Approves Botox to Treat Urinary Incontinence

The U.S. Food and Drug Administration on Wednesday approved the drug to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have an overactive bladder.
Drug shortage

U.S. Vital Medicine Shortage Underscores Need for National Stockpile

U.S. Government officials and Congressional lawmakers, along with drug industry and doctors' groups, are scrambling to find remedies for critical shortages in a number of drugs that treat life-threatening illnesses, including bacterial infection and several forms of cancer.
Ketamine

Dance Club Drug Ecstasy Developed to Cure Cancer

Scientists from the University of Birmingham found that a modified form of Ecstasy (MDMA) could be used in treating myeloma, lymphoma, and leukemia, after scientists modified the drug to increase its tumour-killing properties.
IBTimes Logo

Seattle Genetics: FDA Approves Adcetris to Treat Lymphomas

Adcetris is an antibody-drug that targets a type of lymphoma cell called CD30. It is the first treatment approved by the FDA for fighting Hodgkin lymphoma since 1977, and also the first made to specifically treat anaplastic large cell lymphoma.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.